Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

areholders$
28.0$
94.8$
97.3$
260.9Earnings per share attributable to common shareholders:Basic$
.22$
.76$
.77$
2.10Diluted$
.21$
.75$
.76$
2.06Weighted average shares outstanding:Basic126.2125.1125.8124.5Diluted130.7127.0128.4126.5 The following table presents Actavis' Condensed Consolidated Balance Sheets for the twelve months ended December 31, 2012 and 2011. Table 2Actavis, Inc.Condensed Consolidated Balance Sheets(Unaudited; in millions)December 31,December 31,20122011AssetsCash and cash equivalents$
319.0$
209.3Marketable securities9.014.9Accounts receivable, net 1,291.51,165.7Inventories, net1,543.2889.4Other current assets705.1290.4Property and equipment, net1,479.8713.7Investments and other assets151.993.0Product rights and other intangibles, net3,857.01,613.6Goodwill4,771.41,708.3Total assets$
4,127.9$
,698.3Liabilities & EquityCurrent liabilities$
2,708.0$
,839.5Long-term debt6,257.1848.5Deferred income taxes and other liabilities1,289.4447.8Total equity3,873.43,562.5Total liabilities and equity$
4,127.9$
,698.3 The following table presents Actavis' Condensed Consolidated Statements of Cash Flows for the twelve months ended December 31, 2012 and 2011.

 Table 3Actavis, Inc.Condensed Consolidated Statement of Cash Flows(Unaudited; in millions)Twelve Months EndedDecember 31, 20122011Cash Flows From Operating Activities:Net income$
98.3$
259.1Reconciliation to net cash provided by operating activities:Depreciation97.593.6Amortization481.1354.3Provision for inventory reserve62.544.4Share-based compensation48.839.8Deferred income tax benefit(159.5)(126.9)(Gain) loss on equity method investments(1.3)4.5Gain on sale of securities(28.8)(0.8)Loss on asset sales and impairment, net 58.776.3Loss on foreign exchange derivatives70.4-Amortization of deferred financing costs40.6-Increase in
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Today we bring you a special edition of #MedicareMonday ... remind you about some of our Medicare resources and continue highlighting the success of ... Check out our latest infographics and videos here: ... ... ...
(Date:7/30/2015)... Calif., July 30, 2015  Amgen (NASDAQ: ... second quarter of 2015. Key results include: ... second quarter of 2014 to $5,370 million, with ... Enbrel ® (etanercept), Prolia ® (denosumab), ... and XGEVA ® (denosumab). Unfavorable changes in ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... 5, 2011 Xlumena, Inc., a ... endoscopist and endoscopic surgeon, announced today that it ... AXIOS™ Stent and Delivery System (AXIOS). The AXIOS ... translumenal therapy and is indicated for drainage of ...
... May 5, 2011 A new position ... and Interventions (SCAI) calls for changes in the way ... angioplasty) care is measured and publically reported. The position ... published online in Catheterization and Cardiovascular Interventions ...
Cached Medicine Technology:Xlumena Receives CE Mark for Revolutionary AXIOS™ Stent and Delivery System 2SCAI Releases Position Statement on Public Reporting and Risk Adjustment In Cardiovascular Quality Improvement Programs 2SCAI Releases Position Statement on Public Reporting and Risk Adjustment In Cardiovascular Quality Improvement Programs 3
(Date:8/1/2015)... CA (PRWEB) , ... August 01, 2015 , ... Have you ever wondered what “Karma” ... when you hear the word “Karma.” , Vedic tradition, which gave birth to Hinduism, ... is one of the central concepts of this tradition. According to the wisdom of this ...
(Date:8/1/2015)... ... August 01, 2015 , ... Professional Orthopedic ... company has acquired Premier Physical Therapy & Wellness (“Premier”) — with 13 locations ... clinics. , “Our acquisition of Premier Physical Therapy & Wellness solidifies Professional as ...
(Date:8/1/2015)... ... ... 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery (CCAR) ... Springer Mountain and heading north. Since that day, Phil has hiked over 1400 miles in ... friends and family. He visited CCAR and left an inspirational message to his staff: ...
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on Sunday, ... Bowl. In the two weeks that separate the conference championships and the Super Bowl, there ... game will mark the 50th time it has been held and the festivities will take ...
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight On ... on October 3, 2015. The Ride to Fight On is a cycling fundraiser that ... Healthcare, The West Clinic and The University of Tennessee Health Science Center. A health ...
Breaking Medicine News(10 mins):Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... researchers say estrogen may provide protection against colon cancer. ... to female mice and followed their progress for one year. ... ingredients. ,Diet one contained milk protein, and diet two ... The other three diets contained soy protein with the addition ...
... with clozapine and olanzapine may be at an ... taking these antipsychotic agents resisted insulin // and ... taking another drug under study. ,Researchers evaluated ... who were treated with clozapine (Clozaril), olanzapine (Zyprexa, ...
... quality of life they will have, say researchers according ... in the study . Researchers measured health-related quality of ... and child self-report to assess the physical, emotional, social ... percent of the children studied were not overweight; about ...
... disease has been debated for many years. A recent study shows ... migraine headaches report more chest pain, also known as angina. ... -- seeing what appears to be spots or lines in front ... of chest pain than those without a history of headaches. This ...
... common problem among critically ill patients, regardless of ... can be caused by a number of factors, ... or even some nutritional supplements. Previous studies have ... ,Researchers investigated more than 1,800 consecutive patients admitted ...
... between the level of sex hormones and an increased risk ... hormones estrogen and progesterone play a key role in breast ... cells, receiving and interpreting messages sent by the hormones. Estrogen ... as some breast cancer cells. Previous research has shown a ...
Cached Medicine News:
... specifically designed to work with the EC120 ... a small tank blotter that incorporates the ... buffer requirements and fast transfer rates), with ... blotting such as arcing and buffer depletion. ...
... The XCell II Blot Module allows you to ... to membranes. It fits neatly into the XCell ... the gel/buffer core assembly. It requires less than ... and northern transfers. Tough platinized titanium and stainless ...
... The GENIE is the proven electrophoretic transfer ... ultimate in field uniformity. Its design allows ... electrodes which, when coupled with a low ... charger, creates a high field in volts/cm. ...
Semi-Dry Blotting Unit for 10 x 10cm Gels...
Medicine Products: